HIV remains a significant threat to the lives of people in developing countries and continues to exact a massive toll on the societies it impacts, placing a growing burden on health systems at the expense of other critical health programs. CHAI’s overarching vision for HIV is an efficient and effective response, led fully by the national governments of affected countries, that provides quality prevention and treatment services to all who need it. CHAI will help to make this vision a reality by pursuing the following objectives:
1. Reach universal access to treatment for adults and pediatric patients:
CHAI will continue to support countries to reach universal access to treatment under the new 2013 WHO guidelines, focusing scale-up efforts on countries with a high burden of disease and/or low coverage, and renewing our commitment to pediatric care and treatment.
2. Drive dramatic reduction in HIV-related mortality:
CHAI will increase its focus on reducing mortality through targeted work on early initiation, the management of opportunistic infections such as Cryptococcal meningitis and tuberculosis, and support to partner countries to improve patient retention and address treatment failure.
3. Accelerate the scale-up of proven prevention interventions:
CHAI has played a limited role in the prevention space to date outside of the prevention of mother-to-child transmission but recognizes the need to significantly accelerate progress on proven prevention interventions. Where CHAI can add unique value relative to others, we will provide support to partner countries to achieve elimination of mother-to-child-transmission, aggressively scale up male circumcision, and assess the feasibility and impact of treatment as prevention.
4. Create the fiscal space to achieve these goals:
To enable countries to scale up critical treatment and prevention interventions in light of flat-lining donor support, CHAI will continue its work to optimize the costs of drugs and laboratory tests, drive efficiency gains in service delivery, improve the allocation of existing funding, and support the shift to greater government ownership of the response to reduce the management and overhead costs that international partners can incur.